Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | MAOB | P27338 | 2/20 | 1.00 |
| ▸ | ATM | Q13315 | 2/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419966 | 1.00 | MAOA (1.00) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL28681589 | 0.97 | MAOA (0.95) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL2721424 | 0.85 | MAOA (0.74) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL18287922 | 0.84 | MAOA (0.70) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL11732024 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL11732410 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL11730977 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL5605803 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL875109 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL11730476 | 0.82 | MAOA (0.68) | MAOAMAOBATMHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 814 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590969-B2 | Method and device for detecting urea | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-03-31 | — | — | US | claimed |
| CN-114249766-B | Aromatic phosphine oxide compound containing spiro ring, preparation method thereof and application of aromatic phosphine oxide compound as thermal excitation delayed fluorescence main body material | 黑龙江大学 | 2024-04-26 | — | — | CN | claimed |
| US-20240094214-A1 | METHOD AND DEVICE FOR DETECTING UREA | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2024-03-21 | — | — | US | claimed |
| CN-117625105-A | Epoxy resin adhesive and preparation method and application thereof | 韦尔通科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| WO-2024029528-A1 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES | 学校法人近畿大学 | 2024-02-08 | — | — | WO | claimed |
| WO-2023241652-A1 | PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 广州润尔眼科生物科技有限公司 | 2023-12-21 | — | — | WO | claimed |
| US-11733219-B2 | Detection reagent, detection device, and method for detecting primary amide compound | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2023-08-22 | — | — | US | claimed |
| CN-115753701-A | Urea detection method and device | 财团法人工业技术研究院 | 2023-03-07 | — | — | CN | claimed |
| CN-114230632-B | Acrylamide derivative mimic epitope peptide and application thereof | 华南农业大学 | 2023-01-24 | — | — | CN | claimed |
| CN-110041313-B | Ionic liquid promoted solvent-free synthesis method of 3- (9H-xanthene-9-yl) -1H-indole compound | 河南师范大学 | 2022-11-18 | — | — | CN | claimed |
| US-5175218-A | CROSSLINKING POLYMERS WITH COMPOUNDS CONTAINING XANTHENE GROUPS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-29 | — | — | US | claimed |
| EP-0471794-A4 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | — | 1992-05-06 | — | — | EP | claimed |
| WO-1992006134-A1 | CROSSLINKING POLYMERS WITH COMPOUNDS CONTAINING XANTHENE GROUPS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-16 | — | — | WO | claimed |
| EP-0473411-A1 | Xanthenylamide handle for use in peptide synthesis and methods of producing said handle and support incorporating it | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1992-03-04 | — | — | EP | claimed |
| EP-0471794-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES. | OKLAHOMA MED RES FOUND (US) | 1992-02-26 | — | — | EP | claimed |
| WO-1990013296-A1 | ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1990-11-15 | — | — | WO | claimed |
| US-4813973-A | Modified, water-soluble polymers containing amide groups reacted with xanthydrol and other dyes | THE UNIVERSITY OF TORONTO INNOVATIONS FOUNDATION (CA) | 1989-03-21 | — | — | US | claimed |
| US-4315986-A | DIPHENYMETHANE NUCLEATING AGENTS | EASTMAN KODAK COMPANY (US) | 1982-02-16 | — | — | US | claimed |
| US-4076540-A | IONIC COMPLEX, BORIC ACID COMPOUND, UREA | STOSSEL ERNEST | 1978-02-28 | — | — | US | claimed |
| US-3941811-A | Oxidation process | ROUSSEL-UCLAF (FR) | 1976-03-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590969-B2 | Method and device for detecting urea | XDH, UCHL1, UROD | MAOA 426/4885MAOB 443/4885ATM 976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.